Plasma levels of perphenazine (Trilafon) related to development of extrapyramidal side effects

1981 ◽  
Vol 74 (4) ◽  
pp. 306-309 ◽  
Author(s):  
Lars Bolvig Hansen ◽  
Niels-Erik Larsen ◽  
Per Vesterg�rd
Keyword(s):  
Side Effects ◽  
Plasma Levels ◽  
Extrapyramidal Side Effects

Biperiden and Haloperidol Plasma Levels and Extrapyramidal Side Effects in Schizophrenic Patients

1997 ◽  
Vol 36 (2) ◽  
pp. 69-72 ◽  
Author(s):  
Kurt Meszaros ◽  
Elisabeth Lenzinger ◽  
Kurt Hornik ◽  
Georg Schönbeck ◽  
Reinhold Hatzinger ◽  
...  
Keyword(s):  
Side Effects ◽  
Plasma Levels ◽  
Extrapyramidal Side Effects ◽  
Schizophrenic Patients

Extrapyramidal side-effects and dopamine D2/3receptor binding in substantia nigra

2010 ◽  
Vol 64 (4) ◽  
pp. 233-238 ◽  
Author(s):  
Heli Tuppurainen ◽  
Jyrki T. Kuikka ◽  
Heimo Viinamäki ◽  
Minna Husso ◽  
Jari Tiihonen
Keyword(s):  
Side Effects ◽  
Substantia Nigra ◽  
Extrapyramidal Side Effects ◽  
Dopamine D2

Extrapyramidal side effects of clozapine

1992 ◽  
Vol 6 (2) ◽  
pp. 115-116
Author(s):  
W.W. Fleischhacker ◽  
C. Barnas ◽  
M. Kurz ◽  
H. Hinterhuber ◽  
M. Hummer
Keyword(s):  
Side Effects ◽  
Extrapyramidal Side Effects
Sign in / Sign up

Export Citation Format

Share Document